Tech Meridian ← ENTITY INDEX
PROMY MERIDIAN RU

COMPANY · ENTITY #32303

AlphaGenome 2

Related event timeline, sources and context from the news index.

EVENT TIMELINE

2

MODELS · 2 SOURCES · The Verge AI · The Decoder

DeepMind releases AlphaGenome 2 to predict cell-type‑specific effects of genetic variants

DeepMind unveiled AlphaGenome 2, a successor to AlphaGenome that predicts how DNA variants affect specific cell types and states. Trained on over 100 million single-cell profiles across 68 tissues, the model reportedly detects nearly twice as many expression-altering variants as the prior state of the art and is being made available for non-commercial research via the AlphaGenome API with a limited private preview for commercial use.

8.0

MODELS · 1 SOURCE · Google DeepMind

AlphaGenome 2: conditional DNA sequence model predicts variant effects in specific cell types

AlphaGenome 2 is a next-generation DNA-sequence model that predicts how sequence variants affect molecular readouts (gene expression, chromatin accessibility, histone marks, DNA methylation) in specific human cell types and states. Trained on over 107 million individual cell profiles across 68 tissues, it uses a conditional architecture that takes a biological condition plus a DNA sequence, improves detection of cell-type–specific regulatory variants versus the prior model, supports cross-modality imputation, and is available for non-commercial research via the AlphaGenome API (commercial preview private).

8.0